PTT-22982-53314
4 vaccinations
5 coded responses
20 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 070 / NJ
- Registered
- 2021-11-11
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
F4L-29205-56960
Child or adolescent in my care · Male · 2022-06-29
PDH-21999-64217
Child or adolescent in my care · Male · 2022-07-12
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-02-05
Dose 2 — Moderna
-
2021-11-05
Dose 3 — Moderna
-
2021-11-11
Registered in v-safe
- 2021-11-11
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-09-09
Dose 4 — ModernaCo-administered: Flu
-
2022-09-10
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessFree text: Spotted bruising around injection site, approximately 1 inch in diameterMedDRA releases: 2024-11 · check-in free text available
-
2022-09-11
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: Good · Site: SwellingFree text: Injection site is still bruisedMedDRA releases: 2024-11 · check-in free text available
- 2022-09-12
- 2022-09-16
- 2022-09-23
- 2022-10-02
-
2022-10-07
Survey response — day 28, dose 4MedDRA: Cough, Upper-airway cough syndrome — Feeling: FairFree text: Post nasal drip, coughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
-
2022-12-09
Survey response — 3 months, dose 4MedDRA: Cough, Headache, Ocular discomfort, Oropharyngeal pain, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat, cough, headache, sinus infection, eye pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-12-14
-
2023-03-10
Survey response — 6 months, dose 4MedDRA: Epistaxis, Oropharyngeal pain, Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | No |
| 2 | 2021-02-05 | Moderna | No |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-09-09 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Spotted bruising around injection site, approximately 1 inch in diameter
Systemic reaction (other): Injection site is still bruised
Release 12 — day 28, dose 4
Symptoms: Post nasal drip, cough
Release 12 — 3 months, dose 4
Symptoms: Sore throat, cough, headache, sinus infection, eye pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Epistaxis | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Ocular discomfort | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release